MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Strategies for Success with Life Sciences and Healthcare Projects
By adopting collaborative delivery, leveraging institutional knowledge and rethinking implementation, managers can reshape the design of these vital facilities.
Building Disaster Resilience Through Collaboration
The ability to respond quickly and recover effectively depends on the strength of an organization’s external bonds.
Archer Acquires MemorialCare-Anchored Orange County Medical Office Portfolio
The portfolio consists of outpatient medical office buildings located in Rancho Santa Margarita, Mission Viejo and Costa Mesa.
Life Sciences and Healthcare: Reshaping Institutional Design
Examining the way leaders address the increased pressures and prolonged project timelines can reveal best practices and delivery models.
Arnprior Regional Health Upgrades Building Controls to Improve IEQ
Case study: They wanted to improve the hospital facility’s IEQ to support patient care and reduce long-term operating costs.